OGG1 and ovarian cancer: Polymorphisms of other BER components, notably the glycosidase OGG1, result in an increased risk of ovarian cancer, especially in women who are BRCA1 deficient [60], and are a common finding with up to 63% of women with ovarian cancer carrying these germline variants [61].